Get the Stockscreener App
1.81
4.74%
-0.09
Collplant Biotechnologies Ltd stock is traded at $1.81, with a volume of 24,136.
It is down -4.74% in the last 24 hours and down -4.23% over the past month.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
See More
Previous Close:
$1.90
Open:
$1.85
24h Volume:
24,136
Relative Volume:
0.25
Market Cap:
$23.13M
Revenue:
$2.47M
Net Income/Loss:
$-13.87M
P/E Ratio:
-1.4836
EPS:
-1.22
Net Cash Flow:
$-12.42M
1W Performance:
-9.95%
1M Performance:
-4.23%
6M Performance:
+7.74%
1Y Performance:
-53.47%
1-Day Range:
$1.76
$1.86
1-Week Range:
$1.76
$2.0799
52-Week Range:
$1.31
$4.98
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Name
Collplant Biotechnologies Ltd
Sector
Industry
Phone
-
Address
-
Compare CLGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
1.81 | 24.28M | 2.47M | -13.87M | -12.42M | -1.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-23 | Initiated | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Stock (CLGN) Latest News
What analysts say about CollPlant Biotechnologies Ltd stockMarket Entry Points & Free Stock Predictions and Analysis - earlytimes.in
How CollPlant Biotechnologies Ltd. (CPT) stock trades after earningsWeekly Volume Report & Capital Protection Trading Alerts - Newser
How CollPlant Biotechnologies Ltd. (CPT) stock reacts to monetary easing2025 Geopolitical Influence & Verified Momentum Stock Watchlist - Newser
Can CollPlant Biotechnologies Ltd. stock maintain growth trajectory2025 Top Gainers & Technical Confirmation Trade Alerts - Newser
Is CollPlant Biotechnologies Ltd. (CPT) stock resilient in recession scenariosWall Street Watch & Daily Stock Trend Watchlist - Newser
Can CollPlant Biotechnologies Ltd. stock hit record highs againWeekly Investment Recap & Weekly High Conviction Ideas - Newser
Is CollPlant Biotechnologies Ltd. (CPT) stock a top pick for value investorsJuly 2025 Pullbacks & Stepwise Trade Signal Implementation - Newser
Is CollPlant Biotechnologies Ltd. stock a buy in volatile marketsPortfolio Gains Report & Verified Stock Trade Ideas - Newser
Will CollPlant Biotechnologies Ltd. (CPT) stock deliver stable dividends2025 Price Action Summary & Fast Entry Momentum Alerts - Newser
What MACD trends signal for CollPlant Biotechnologies Ltd. (CPT) stockMarket Trend Review & Verified Technical Signals - Newser
CollPlant Biotechnologies Reports Q3 2025 Financial Results - MSN
Is CollPlant Biotechnologies Ltd. overvalued or undervalued? - Markets Mojo
CollPlant Biotechnologies’ (CLGN) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World
D. Boral Capital Maintains CollPlant Biotechnologies (CLGN) Buy Recommendation - Nasdaq
CLGN Analyst Rating Maintained: November 2025 Update | CLGN Stoc - GuruFocus
CollPlant Biotechnologies schedules annual and extraordinary meeting for December 31 - Investing.com Nigeria
CollPlant Biotechnologies Announces Annual and Extraordinary General Meeting for December 2025 - TipRanks
[6-K] CollPlant Biotechnologies Ltd Current Report (Foreign Issuer) | CLGN SEC FilingForm 6-K - Stock Titan
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
CollPlant (CLGN) Sees Significant Q3 Revenue Growth and Advances in Bioprinting - GuruFocus
CLGN Stock Crashed 14% Today – Disappointing Earnings, Workforce Reduction Plan Draws Investor Attention - Stocktwits
CollPlant shares edge down as Q3 revenue falls short of estimates - Investing.com Australia
CollPlant shares edge down as Q3 revenue falls short of estimates By Investing.com - Investing.com South Africa
CollPlant Biotechnologies' Q3 revenue rises on rhCollagen sales, cuts workforce - TradingView
CLGN: Revenue and net loss improved year-over-year, with expanded North American operations and new product milestones - TradingView
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PR Newswire
CollPlant Biotechnologies's Earnings Outlook - Sahm
Is CollPlant Biotechnologies Ltd a good long term investmentPrice Action Trading & Free Risk Assessment and Control - earlytimes.in
Can CollPlant Biotechnologies Ltd. stock sustain market leadership2025 Top Decliners & Growth Focused Stock Reports - newser.com
Why CollPlant Biotechnologies Ltd. stock is rated strong buy2025 Market Overview & Long-Term Growth Stock Strategies - newser.com
How CollPlant Biotechnologies Ltd. stock trades during market volatility2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com
Is CollPlant Biotechnologies Ltd. stock trading at a premium valuation2025 Retail Activity & Reliable Trade Execution Plans - newser.com
Why CollPlant Biotechnologies Ltd. (CPT) stock could be top winner2025 Retail Activity & Target Return Focused Stock Picks - newser.com
Is CollPlant Biotechnologies Ltd. forming a bottoming baseJuly 2025 Retail & Verified Momentum Watchlists - newser.com
How analysts rate CollPlant Biotechnologies Ltd. stock today2025 Market WrapUp & Verified Momentum Stock Watchlist - newser.com
Collplant Biotechnologies Ltd Stock (CLGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):